Regulatory registrations


Field trials in USA in 2014, 2015.

Food Additives:

GRAS status for our first colicin products in:

GRAS status for our thaumatin sweetener in:

GRAS status for Clostridium bacteriophage endolysins in:

Bacteriocin preparations specific to Salmonella in:


  • GMP certification of the facility in Halle, Germany (divested with ICON)
  • successful Phase I trials in USA with NHL cancer vaccine
  • Phase I-II with ZMapp anti-Ebola therapy (based on our technology)


Clear regulatory path for products based on our proprietory manufacturing process.